The Diagnostic Imaging mammography modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of mammography, including 2D digital mammography, digital breast tomosynthesis, and breast ultrasound.
May 13th 2025
Emerging research suggests that radiomic breast texture features extracted from full-field digital mammography may bolster prognostic assessments of invasive breast cancer risk beyond traditional risk factors.
Clinical Case Vignette Series™: 41st Annual Miami Breast Cancer Conference®
View More
Medical Crossfire®: How Can Thoracic Teams Facilitate Optimized Care of Patients With Stage I-III EGFR Mutation-Positive NSCLC?
View More
Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?
View More
26th Annual International Lung Cancer Congress®
July 25-26, 2025
Register Now!
2025 International Symposium of Gastrointestinal Oncology (ISGIO)
September 12-13, 2025
Register Now!
Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection
View More
(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure
View More
(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment
View More
43rd Annual CFS: Innovative Cancer Therapy for Tomorrow®
November 12-14, 2025
Register Now!
20th Annual New York Lung Cancers Symposium®
November 15, 2025
Register Now!
Annual Hawaii Cancer Conference
January 24-25, 2026
Register Now!
43rd Annual Miami Breast Cancer Conference®
March 5-8, 2026
Register Now!
19th Annual New York GU Cancers Congress™
March 13-14, 2026
Register Now!
Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies
View More
(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice
View More
It takes a team to keep tight ship on course
November 1st 2006I routinely read and enjoy the column by Dr. Bradley Tipler. But I was shocked and disappointed by the article in the June 2006 edition, ("Command of a tight ship stays out of reach," page 64). I work on the other side of the table.
Digital mammography begins to deliver hope
November 1st 2006For years, the world of breast imaging was quite simple. Screen-film mammography and ultrasound did not leap ahead, but they did a satisfactory job for most women. In the past few years, the armamentarium has exploded, with the introduction of modalities from MRI to vacuum biopsy. The management of breast disease has changed significantly.
Updated breast screening study revives controversy
October 31st 2006The validity of population-based breast screening has once again been called into question by the world’s media. The negative headlines have, ironically, been triggered by a report that finds mammography screening saves lives. But it is the concurrent likelihood of overdiagnosis that has captured journalists’ attention.
Hologic top exec ties growth to long-term goals
October 12th 2006Six years ago, Hologic looked like a company on the brink. Once the darling of the radiology industry with booming sales of bone densitometers, Hologic had sought to diversify, but its acquisitions were dragging the company down rather than lifting it up.
Hologic plans multiple modality unveilings at RSNA meeting
October 11th 2006Buoyed by corporate acquisitions, Hologic will appear at the RSNA meeting with a 13,000-square-foot booth filled with works-in-progress for its mammography, CAD, and densitometry offerings, and enhanced by a first-time RSNA showing of an MRI system from Esaote and the Chicago debut of its newly acquired biopsy portfolio.
Siemens plans launch of prone biopsy system
September 26th 2006Siemens Medical Solutions will launch its newly acquired MammoTest breast biopsy table at the RSNA meeting. The rights to the system were acquired by Siemens this summer from now-defunct Fischer Imaging in a deal brokered by the Federal Trade Commission. By late November, the company expects that its managers in every country will be versed in the prone stereotactic biopsy unit and ready to begin selling it globally, said Erica Rouleau, national sales director for women’s health at Siemens.
iCAD hatches plan to dominate mammography CAD
September 12th 2006FujiFilm Medical Systems USA has forged a key distribution agreement with iCAD to serve as a supplier of computer-aided detection products for Fuji’s CR mammography. As important as this deal is to Fuji, it may be even more important for iCAD.
Personal contact proves key to increasing mammography compliance
August 17th 2006More mammography facilities closed in the U.S. than opened for business between 2001 and 2004, according to a report by the Government Accountability Office released Aug. 16. The report concludes that current supply is sufficient to meet the demand, but the GAO’s reason is an indictment of U.S. healthcare.
Technology changes drive new x-ray standards
August 16th 2006The National Electrical Manufacturers Association has published two new standards for manufacturers of hard-copy and soft-copy reading devices for full-field digital mammography. The FDA-sanctioned documents should help breast imaging facilities meet their obligations under the Mammography Quality Standards Act.
Google-like system speeds mammography interpretations
August 9th 2006Medical physicists at Duke University are employing an approach similar to the one used by millions of Internet users daily to obtain computer-driven second opinions on mammograms demonstrating suspicious breast masses. The Google-like approach compares questionable mammograms with selected images ranked to reflect the likely value of their information content.